|
US9340577B2
(en)
|
1992-08-07 |
2016-05-17 |
Epimmune Inc. |
HLA binding motifs and peptides and their uses
|
|
US6183746B1
(en)
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
|
US6013258A
(en)
*
|
1997-10-09 |
2000-01-11 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
|
EP1064022A4
(en)
*
|
1998-03-13 |
2004-09-29 |
Epimmune Inc |
HLA BINDING PROTEINS AND THEIR USE
|
|
WO2000044775A2
(en)
*
|
1999-01-27 |
2000-08-03 |
Epimmune Inc. |
Identification of broadly reactive hla restricted t cell epitopes
|
|
US7361338B2
(en)
|
1999-10-05 |
2008-04-22 |
Agensys, Inc. |
Methods to inhibit growth of prostate cancer cells
|
|
AU1661201A
(en)
*
|
1999-11-18 |
2001-05-30 |
Epimmune, Inc. |
Heteroclitic analogs and related methods
|
|
US7462354B2
(en)
|
1999-12-28 |
2008-12-09 |
Pharmexa Inc. |
Method and system for optimizing minigenes and peptides encoded thereby
|
|
EP2075582A3
(en)
|
2000-07-12 |
2010-01-06 |
Agensys, Inc. |
Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
|
|
CA2705366A1
(en)
|
2000-08-28 |
2002-03-07 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
|
|
AU2002246708A1
(en)
|
2000-12-15 |
2002-08-12 |
Agensys, Inc. |
Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
|
|
US6924358B2
(en)
|
2001-03-05 |
2005-08-02 |
Agensys, Inc. |
121P1F1: a tissue specific protein highly expressed in various cancers
|
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
|
US20030191073A1
(en)
|
2001-11-07 |
2003-10-09 |
Challita-Eid Pia M. |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
|
|
US7736654B2
(en)
|
2001-04-10 |
2010-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
IL158860A0
(en)
*
|
2001-05-15 |
2004-05-12 |
Agensys Inc |
Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer and pharmaceutical compositions containing the same
|
|
US20060222656A1
(en)
|
2005-04-01 |
2006-10-05 |
University Of Maryland, Baltimore |
MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
|
|
AU2002322009A1
(en)
|
2001-05-18 |
2002-12-03 |
Mayo Foundation For Medical Education And Research |
Chimeric antigen-specific t cell-activating polypeptides
|
|
ES2537074T3
(es)
|
2001-09-06 |
2015-06-02 |
Agensys, Inc. |
Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer
|
|
EP1495322A4
(en)
*
|
2002-04-05 |
2006-09-06 |
Epimmune Inc |
HETEROKLITIC ANALOGUES AND ASSOCIATED METHODS
|
|
WO2004000873A2
(en)
*
|
2002-06-25 |
2003-12-31 |
City Of Hope |
Adjuvant-free peptide vaccine
|
|
WO2004016733A2
(en)
|
2002-08-16 |
2004-02-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
|
JP2006508163A
(ja)
|
2002-11-27 |
2006-03-09 |
アジェンシス， インコーポレイテッド |
癌の処置および検出において有用な２４ｐ４ｃ１２と称される、核酸および対応タンパク質
|
|
CA2515699C
(en)
|
2003-02-10 |
2015-01-27 |
Aya Jakobovits |
Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
|
|
RU2005141341A
(ru)
|
2003-05-30 |
2006-06-10 |
Эйдженсис, Инк., Сша (Us) |
Полинуклеотид, родственный антигену стволовых клеток простаты (psca), и кодируемый им белок (пептид), гибридома и трансгенное животное для продуцирования антител, композиция для лечения, профилактики, диагностики и прогноза течения раковых заболеваний на их основе (варианты), способ определения их присутствия в исследуемом образце, способ генерации иммунного ответа, способ доставки цитотоксического или диагностического агента в клетку, способ ингибирования роста раковых клеток с их использованием
|
|
AU2005250370B2
(en)
|
2004-05-28 |
2010-04-01 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
|
CA2603093A1
(en)
|
2005-03-31 |
2006-10-05 |
Agensys, Inc. |
Antibodies and related molecules that bind to 161p2f10b proteins
|
|
WO2007083807A1
(ja)
*
|
2006-01-23 |
2007-07-26 |
Green Peptide Co., Ltd. |
Ｃ型肝炎ウイルス由来ペプチド
|
|
JP5067624B2
(ja)
|
2006-02-07 |
2012-11-07 |
日本電気株式会社 |
Ｈｌａ結合性ペプチド、それをコードするｄｎａ断片および組み換えベクター
|
|
JPWO2008044567A1
(ja)
|
2006-10-12 |
2010-02-12 |
日本電気株式会社 |
Ｈｌａ結合性ペプチド、その前駆体、それをコードするｄｎａ断片および組み換えベクター
|
|
JP2011502484A
(ja)
|
2007-11-01 |
2011-01-27 |
メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ |
Ｈｌａ−ｄｒ結合性ペプチドおよびそれらの使用
|
|
EP2391635B1
(en)
*
|
2009-01-28 |
2017-04-26 |
Epimmune Inc. |
Pan-dr binding polypeptides and uses thereof
|
|
CN103906531A
(zh)
|
2011-05-26 |
2014-07-02 |
金纽斯生物科技投资有限责任公司 |
调节的免疫优势疗法
|
|
MA47678A
(fr)
|
2017-03-03 |
2021-05-26 |
Treos Bio Ltd |
Plateforme personnalisée d'identification de peptide immunogène
|
|
KR20210086612A
(ko)
|
2018-09-04 |
2021-07-08 |
트레오스 바이오 리미티드 |
펩타이드 백신
|
|
CN116710115A
(zh)
|
2020-11-20 |
2023-09-05 |
思维疗法股份有限公司 |
用于优化的肽疫苗的组合物和方法
|
|
US11421015B2
(en)
|
2020-12-07 |
2022-08-23 |
Think Therapeutics, Inc. |
Method of compact peptide vaccines using residue optimization
|
|
US11058751B1
(en)
|
2020-11-20 |
2021-07-13 |
Think Therapeutics, Inc. |
Compositions for optimized RAS peptide vaccines
|
|
US11161892B1
(en)
|
2020-12-07 |
2021-11-02 |
Think Therapeutics, Inc. |
Method of compact peptide vaccines using residue optimization
|
|
US11464842B1
(en)
|
2021-04-28 |
2022-10-11 |
Think Therapeutics, Inc. |
Compositions and method for optimized peptide vaccines using residue optimization
|